Page last updated: 2024-08-22

tranylcypromine and Migraine Disorders

tranylcypromine has been researched along with Migraine Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GOTTFRIES, CG1
Eyer, F; Jetzinger, E; Pfab, R; Zilker, T1
Bloom, DS; Eidelman, BH; McCalden, TA; Mendelow, AD1

Other Studies

3 other study(ies) available for tranylcypromine and Migraine Disorders

ArticleYear
[Drug therapy of migraine. A communication occasioned by information in the daily press].
    Svenska lakartidningen, 1963, May-22, Volume: 60

    Topics: Cardiovascular Agents; Communication; Ergot Alkaloids; Humans; Migraine Disorders; Oxytocics; Tranylcypromine; Trifluoperazine

1963
Withdrawal from high-dose tranylcypromine.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:3

    Topics: Adult; Antidotes; Delirium; Heroin Dependence; Humans; Infusions, Intravenous; Male; Migraine Disorders; Monoamine Oxidase Inhibitors; Physostigmine; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine

2008
Potentiation of the cerebrovascular response to intra-arterial 5-hydroxytryptamine.
    The American journal of physiology, 1978, Volume: 234, Issue:3

    Topics: Animals; Brain; Carotid Arteries; Cerebral Arteries; Cerebrovascular Circulation; Estrogens; Female; Haplorhini; Infusions, Intra-Arterial; Lipoproteins, LDL; Male; Migraine Disorders; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Papio; Progesterone; Serotonin; Tranylcypromine

1978